Quest Diagnostics Q4 rev $2.81B (+7.1%), adj EPS $2.42 (+8.5%); raises dividend 7.5%

QUEST DIAGNOSTICS INC

2025-FY EPS reported $8.75 revenue$11,035,000,000

FY2025 revenue $11.04B (+11.8%), reported EPS $8.75 (+13.8%), adjusted EPS $9.85 (+10.3%).
Q4 organic requisition volume +7.9%; operating cash flow $465M; FY cash from ops $1.89B.
FY2026 guidance: revenue $11.70B-$11.82B, adjusted EPS $10.50-$10.70.
Quarterly dividend raised 7.5% to $0.86/share, payable Apr 20, 2026 to holders of record Apr 6, 2026.
Board authorized additional $1B share repurchase; $0.4B remained from prior program.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.